rfhg_217615.1

Basic information about the TSS

---

TSS ID: rfhg_217615.1 Species: human Chr: chr20		Start: 4686675 End: 4686699 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3272762,EH38E2094400)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000457586.2:-132 GeneID: 5621 HGNC/MGI_ID: HGNC:9449 UniProt_ID: X6RKS3 Nearer transcript ids and distances:

Gene_name: PRNP Gene_symbol: PRNP Gene_synonyms: AltPrP CD230 PRP Gene_source: HGNC:9449

TATA-Box annotation

---

Distance to TSS:	231
Nearest PromoterID:	NM_183079
Entrez ID:	5621
Nearest Unigene:	Hs.472010
Nearest Refseq:	NM_000311
Nearest Ensembl:	ENSG00000171867
Gene Name:	PRNP
Gene Alias:	ASCR|AltPrP|CD230|CJD|GSS|KURU|PRIP|PrP|PrP27-30|PrP33-35C|PrPc|p27-30
Gene Type:	protein-coding
CpG%:	0.125000
GC%:	0.800000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PRNP p2@PRNP p4@PRNP p7@PRNP p9@PRNP
Sample		p1@PRNP	p2@PRNP	p4@PRNP	p7@PRNP	p9@PRNP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	75.19	5.65	0.39	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	92.46	8.50	1.21	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	99.54	8.87	0.96	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	76.10	7.90	0.62	0.62	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	95.39	8.77	1.12	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	83.14	7.95	0.19	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	79.09	10.68	0.87	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	69.03	5.81	0.97	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	73.30	9.19	0.64	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	82.31	21.45	0.00	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	67.91	12.13	0.81	0.00	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	74.81	17.89	0.81	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	46.10	3.22	0.32	0.97	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	47.21	2.10	0.75	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	33.59	3.07	0.88	1.10	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	40.99	3.02	1.01	1.26	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	43.46	3.06	0.44	0.87	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	40.92	1.27	1.69	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	42.12	3.20	0.00	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	52.80	2.86	1.05	0.90	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	44.51	2.81	1.34	0.80	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	49.72	2.76	0.17	0.86	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	48.60	3.10	1.03	1.94	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	52.17	1.94	0.73	0.97	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	47.73	3.35	0.77	0.52	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	49.38	3.48	1.27	0.32	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	45.06	2.20	1.65	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	59.41	3.77	1.41	1.18	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	49.43	2.91	0.81	1.29	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	46.69	3.44	1.27	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	44.80	4.81	1.88	0.84	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.75	4.49	1.17	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	39.67	2.32	1.48	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	53.28	1.98	1.15	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	54.04	3.18	2.06	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	42.35	2.87	0.57	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	42.92	5.52	1.02	1.23	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	47.35	2.22	1.01	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	44.03	4.32	1.08	2.16	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	48.01	1.68	1.92	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	48.46	2.35	1.18	0.94	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	49.33	3.07	1.90	0.73	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	44.29	1.90	1.05	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	41.26	4.20	1.05	0.17	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	39.35	2.21	1.00	1.20	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	39.78	4.42	2.79	1.86	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	41.98	4.32	0.72	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.85	5.07	1.49	1.19	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	30.16	3.83	0.48	0.24	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	30.94	3.03	0.40	0.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	28.08	2.87	2.05	1.02	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	41.14	2.45	0.67	0.44	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	38.32	2.48	0.71	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	42.75	3.65	0.33	1.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	23.49	4.19	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.52	2.30	0.46	0.46	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	34.68	1.94	0.97	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	25.69	3.53	1.61	0.32	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	26.40	2.51	1.26	0.63	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.78	2.12	1.41	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	39.82	3.93	1.68	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	13.53	2.39	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.44	3.06	0.00	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.52	3.25	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	41.89	2.48	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	57.53	0.49	1.95	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	50.08	2.98	1.49	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	54.89	0.94	0.94	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	58.62	4.97	1.32	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	54.44	2.17	1.55	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	57.48	3.67	0.31	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	141.44	5.86	0.95	0.48	0.48
Adipocyte - breast, donor2	11327-117E4	106.04	3.21	1.28	0.00	0.48
Adipocyte - omental, donor1	11473-119C6	257.13	5.98	0.89	0.64	0.76
Adipocyte - omental, donor2	11474-119C7	170.43	6.73	3.74	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	122.58	1.34	2.01	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	172.90	4.47	3.19	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	46.18	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	191.04	10.84	0.00	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	153.97	2.43	2.26	1.04	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	202.61	15.25	1.37	0.78	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	89.83	7.21	0.26	0.77	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	171.45	12.82	0.28	1.39	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	208.08	7.64	0.00	2.35	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	164.97	4.02	0.16	0.64	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	112.64	3.55	1.29	0.00	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	154.62	5.33	1.07	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	135.21	3.34	1.67	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	129.34	3.33	0.83	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	111.52	4.27	0.50	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	173.77	6.54	0.33	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	99.87	2.74	0.00	0.61	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	33.15	4.42	0.00	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	8.96	0.72	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	133.67	6.84	0.36	0.90	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	95.94	4.31	0.41	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	29.41	2.98	0.34	0.46	0.34
Anulus Pulposus Cell, donor2	11463-119B5	23.51	1.96	0.00	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	236.33	26.96	5.39	0.90	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	284.36	34.30	2.17	0.87	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	237.57	29.96	6.42	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	225.09	30.79	2.69	0.90	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	269.37	24.03	10.12	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	223.10	14.52	4.62	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	244.96	28.27	2.60	1.95	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	259.71	38.35	2.43	2.91	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	239.33	19.60	7.13	2.97	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	265.15	32.77	2.26	0.00	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	226.41	29.75	6.53	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	234.46	21.31	2.51	1.25	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	397.51	35.25	0.99	1.32	1.15
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	195.17	27.30	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	289.52	20.51	2.26	1.21	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	253.96	25.72	5.36	2.68	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	259.22	36.65	3.40	1.70	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	305.24	22.18	2.41	1.34	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	185.34	25.36	4.88	1.95	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	283.62	28.86	1.99	1.49	2.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	265.36	22.81	8.41	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	205.33	14.16	10.62	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	314.07	34.31	1.54	1.20	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	264.28	8.39	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	250.48	28.15	4.37	1.46	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	357.06	33.77	3.79	1.90	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	253.18	31.50	4.85	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	232.00	33.06	3.99	1.14	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	296.72	32.92	2.35	1.71	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	244.93	22.45	1.81	1.81	2.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	273.55	25.34	2.82	0.94	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	259.49	32.48	1.93	0.64	2.89
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	229.73	19.26	2.85	2.85	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	261.47	26.91	2.34	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	268.86	28.90	3.61	1.81	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	253.04	9.50	11.88	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	271.57	26.95	8.14	1.53	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	262.58	33.36	8.40	1.02	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	221.11	25.41	2.54	1.27	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	246.41	31.93	2.16	1.29	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	262.49	34.50	3.60	1.27	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	229.67	20.88	3.48	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	260.75	22.67	5.67	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	279.55	33.90	2.03	1.86	1.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	233.95	23.16	2.32	0.00	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	183.79	27.46	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	265.23	25.52	1.93	0.86	1.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	267.74	15.64	4.21	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	219.42	23.33	4.37	2.19	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	295.17	32.18	2.76	0.69	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	257.58	25.50	17.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	401.94	28.22	4.07	1.02	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	297.69	30.35	2.48	1.45	2.06
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	255.51	21.11	3.67	1.22	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	258.13	35.37	4.30	1.91	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	255.22	25.06	3.10	1.33	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	265.49	30.52	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	251.47	24.92	4.43	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	258.70	30.19	2.65	1.85	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	262.77	19.63	2.18	0.73	1.09
Astrocyte - cerebellum, donor1	11500-119F6	54.16	3.44	0.25	0.12	0.12
Astrocyte - cerebellum, donor2	11580-120F5	33.03	3.59	0.17	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	24.75	2.31	0.00	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	82.27	5.58	0.00	1.74	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	61.31	5.66	0.32	0.97	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	61.75	3.28	0.30	0.60	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	21.90	1.03	0.11	0.23	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	20.17	0.75	0.00	0.38	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	16.50	0.80	0.11	0.11	0.00
Basophils, donor1	12241-129G9	195.10	4.18	0.78	0.00	0.26
Basophils, donor2	12242-129H1	200.96	3.97	0.36	0.00	0.00
Basophils, donor3	12243-129H2	206.97	7.50	0.15	1.32	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	117.93	13.58	0.65	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	37.49	3.66	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	215.21	21.52	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	84.11	8.79	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	96.07	13.52	0.62	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	173.87	42.37	2.30	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	226.55	19.25	2.34	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	40.19	0.52	0.21	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	37.26	0.47	0.70	0.47	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	62.68	1.60	0.00	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	209.64	11.83	1.13	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	205.27	7.98	1.11	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	150.60	7.90	1.32	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	382.96	3.68	0.85	8.21	2.26
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	275.59	0.76	1.52	3.79	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	405.01	0.99	0.66	4.60	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	278.11	25.30	0.87	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	245.02	26.25	2.41	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	221.02	25.11	1.18	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	232.01	31.64	0.67	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	254.48	51.89	0.83	0.28	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	314.37	57.77	1.24	0.50	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	328.55	212.84	2.74	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	258.17	162.02	1.25	0.71	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	388.91	235.69	5.66	0.44	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	251.92	132.52	2.11	1.40	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	258.21	114.58	2.64	1.58	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	292.87	108.72	3.33	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	295.27	35.10	1.64	0.59	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	295.33	40.51	2.00	0.60	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	332.08	41.02	0.83	2.29	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	366.06	183.03	2.06	0.69	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	357.63	118.08	2.04	1.13	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	302.03	144.90	1.31	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	216.81	23.67	0.81	0.27	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	194.00	57.57	1.40	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	262.59	39.56	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	246.17	71.65	1.47	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	269.13	81.73	0.35	0.70	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	265.87	77.65	0.88	0.44	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	282.14	307.94	3.66	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	285.82	292.51	5.95	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	450.71	377.43	5.39	0.43	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	192.87	38.08	0.00	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	266.11	69.08	0.23	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	255.42	50.81	0.93	1.16	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	76.29	1.09	1.09	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	134.90	1.62	0.92	0.92	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	97.26	2.60	0.65	0.22	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	131.27	2.49	0.93	0.47	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	169.23	3.32	1.05	1.40	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	143.82	3.57	0.67	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	54.35	1.53	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	108.90	1.10	0.88	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	89.48	0.84	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	42.68	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	54.92	0.00	0.68	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	72.49	0.00	1.04	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	102.88	0.00	0.53	1.60	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	94.35	0.00	0.00	0.54	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	47.73	0.70	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	61.96	0.00	0.00	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	75.14	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	86.30	0.00	1.64	0.82	1.64
CD19+ B Cells, donor2	11624-122B4	81.97	2.18	0.73	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	95.92	1.01	2.02	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	52.93	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	39.55	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	14.06	1.00	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	154.50	3.37	0.56	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	49.98	0.00	0.38	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	47.35	0.90	0.00	0.45	0.90
CD4+ T Cells, donor1	11225-116C1	202.09	1.43	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	205.75	1.84	2.45	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	184.22	2.13	0.61	0.91	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	94.95	0.51	0.51	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	81.53	0.22	0.22	1.35	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	89.11	0.29	0.57	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	88.66	1.90	0.47	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	77.26	0.00	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	162.00	3.90	0.43	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	195.73	6.44	2.54	1.02	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	155.72	5.48	1.45	0.32	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	150.18	1.34	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	156.18	2.10	1.40	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	145.19	0.44	1.32	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	56.92	0.84	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	52.98	0.83	0.62	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	65.49	0.67	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	94.91	1.09	0.54	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.92	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	66.35	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	138.33	1.48	0.19	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	130.19	2.38	0.43	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	146.48	1.68	1.05	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	80.39	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	116.11	0.87	0.43	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	90.21	0.44	1.31	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	122.73	2.47	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	94.16	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	106.08	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	173.08	0.83	0.00	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	160.73	1.47	0.49	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	157.08	4.62	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	175.12	1.79	0.72	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	159.27	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	333.94	3.93	0.65	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	273.69	6.01	1.88	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	197.19	3.03	1.26	0.25	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	49.09	1.15	0.69	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	46.49	1.20	0.96	0.00	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	39.12	0.82	0.55	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	53.74	0.90	0.00	0.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	45.84	2.16	0.48	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	43.66	0.91	0.23	0.68	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	41.07	1.52	0.00	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	44.48	1.58	0.53	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	41.98	0.94	0.00	0.70	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	48.30	1.21	0.91	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	43.87	2.61	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	49.56	1.60	0.00	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	96.74	10.07	0.44	0.88	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	83.34	12.30	0.46	0.91	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	64.89	7.46	0.75	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	68.43	3.96	0.00	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	52.37	2.30	0.29	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	44.78	2.12	0.00	0.00	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	58.63	1.58	0.32	1.27	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	58.44	1.85	0.31	0.92	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	55.78	1.60	0.64	0.64	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	76.88	3.06	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	74.09	1.97	0.39	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	68.83	3.78	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	85.11	4.82	1.61	2.41	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	102.12	6.99	0.70	4.20	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	90.16	6.01	1.00	5.01	3.01
Cardiac Myocyte, donor1	11525-119I4	116.98	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	62.26	1.98	1.48	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	134.80	4.84	0.21	0.32	0.95
Chondrocyte - de diff, donor1	11261-116G1	131.04	8.32	1.39	0.00	1.04
Chondrocyte - de diff, donor2	11338-117F6	91.69	1.78	0.36	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	126.41	5.35	0.91	1.71	0.57
Chondrocyte - re diff, donor2	11339-117F7	76.99	3.58	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	45.29	4.04	0.40	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	40.17	3.67	0.34	0.34	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	43.18	4.70	0.64	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	41.15	2.57	0.18	0.44	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	289.59	6.42	0.92	2.84	2.20
Corneal Epithelial Cells, donor1	11526-119I5	115.93	35.57	0.44	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	137.65	19.34	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	108.13	35.28	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	120.85	1.49	1.16	0.50	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	129.32	1.89	0.00	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	82.82	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	124.73	1.62	0.54	0.54	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	108.30	0.34	0.00	1.02	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	86.18	0.65	0.00	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	105.02	0.48	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	62.71	5.84	0.17	0.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	37.55	1.76	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	61.08	3.39	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	50.72	4.72	0.00	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	27.92	3.20	0.00	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	52.23	3.53	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	37.87	3.16	0.53	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	110.83	4.88	0.66	1.33	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	171.91	17.34	0.91	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	143.77	6.48	0.28	1.41	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	68.34	3.27	0.59	1.49	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	39.57	1.56	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	57.85	2.13	0.28	0.57	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	140.04	7.20	1.60	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	42.45	2.62	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	105.49	3.98	0.12	0.87	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	54.10	2.39	0.00	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	50.44	2.93	0.12	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	37.54	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	44.70	2.79	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	41.45	3.14	0.00	0.16	0.16
Eosinophils, donor1	12244-129H3	106.73	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	97.37	8.25	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	71.34	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	93.82	10.51	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	87.37	12.48	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	292.84	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	101.81	2.87	0.00	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	813.17	196.09	33.17	3.39	2.52
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.41	2.38	0.65	0.11	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	167.97	10.43	1.82	0.36	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1288.56	375.16	2.18	7.10	2.87
Fibroblast - Aortic Adventitial, donor2	11326-117E3	450.99	76.25	4.43	1.37	1.58
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	692.45	60.87	6.85	3.16	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	163.77	26.91	1.99	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	64.42	4.08	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	37.90	4.55	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	117.50	5.20	0.95	0.79	0.47
Fibroblast - Cardiac, donor4	11452-119A3	194.29	12.73	0.00	3.64	0.61
Fibroblast - Cardiac, donor5	11456-119A7	99.24	6.73	1.02	1.27	0.51
Fibroblast - Cardiac, donor6	11460-119B2	45.18	2.73	0.45	0.00	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	103.98	5.49	0.40	0.40	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	82.83	4.75	0.00	1.73	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	84.96	16.11	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	106.56	11.07	0.23	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	135.51	6.61	1.02	3.56	0.85
Fibroblast - Dermal, donor1	11269-116G9	139.23	13.15	0.47	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	74.53	7.08	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	164.28	8.58	1.69	0.85	0.12
Fibroblast - Dermal, donor4	11450-119A1	65.00	7.69	0.23	0.23	0.11
Fibroblast - Dermal, donor5	11454-119A5	73.44	5.93	0.87	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	67.73	4.87	0.32	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	82.88	3.12	0.62	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	143.31	5.24	0.79	0.79	0.26
Fibroblast - Gingival, donor2	11318-117D4	66.55	5.27	0.66	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	115.35	4.16	0.10	0.68	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	323.10	16.62	0.00	3.12	5.19
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	208.10	10.22	2.11	1.59	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	94.16	3.90	0.78	0.47	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	153.21	5.27	1.08	0.54	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	115.04	4.59	0.00	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	87.16	4.24	0.44	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	79.36	3.82	0.27	0.00	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	114.19	6.25	0.99	0.11	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	242.12	9.83	2.20	2.05	1.32
Fibroblast - Lung, donor1	11270-116H1	20.39	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	92.51	4.48	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	56.14	2.11	0.21	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	149.94	8.33	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	88.11	6.99	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	44.78	1.96	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	142.50	9.34	0.00	0.41	0.81
Fibroblast - Mammary, donor2	11620-122A9	35.95	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	148.91	17.87	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	74.49	5.43	0.19	0.58	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	74.02	7.89	0.30	0.61	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	118.72	7.04	0.00	1.22	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	123.26	6.49	0.00	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	140.12	7.29	2.16	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	174.31	10.21	0.81	1.39	1.74
Fibroblast - Pulmonary Artery, donor1	11250-116E8	84.67	4.09	0.55	0.88	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	130.45	10.77	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	36.08	4.01	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	83.82	3.95	0.40	2.37	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	292.31	21.43	2.58	0.60	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	308.17	10.12	0.89	1.60	1.24
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	319.47	13.20	1.58	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	438.95	34.00	1.81	0.30	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	246.78	14.57	1.08	0.11	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	223.21	12.15	1.27	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	304.20	12.31	0.33	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	374.15	18.25	0.60	2.21	0.80
Fibroblast - skin normal, donor2	11561-120D4	185.86	10.35	0.80	0.30	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	171.67	9.97	1.21	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	251.27	11.27	0.66	1.08	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	265.32	17.27	2.22	1.54	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	455.21	23.65	1.97	1.31	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	254.16	19.28	1.70	0.32	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	132.08	8.27	0.67	0.51	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	180.19	8.63	3.92	0.00	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	81.92	1.74	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	548.50	78.88	3.12	1.73	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	475.98	47.62	2.86	1.30	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	415.72	72.82	0.77	2.81	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.84	1.53	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	1.91	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	11.98	1.43	0.00	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	8.00	0.28	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	11.42	0.46	0.00	0.00	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	9.51	2.18	0.20	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.61	0.26	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	14.68	0.00	0.00	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	12.38	3.98	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.84	3.53	0.28	1.27	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.91	4.93	0.25	0.74	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	31.70	4.84	0.00	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	64.80	10.53	0.25	1.61	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	78.49	18.96	0.55	1.25	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	61.80	12.60	0.61	1.22	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	69.59	4.34	0.00	2.74	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	91.56	6.23	0.75	1.49	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	81.31	9.62	0.44	1.97	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	73.28	1.77	0.00	2.07	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	75.19	5.25	0.64	0.32	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	89.37	4.24	0.00	2.23	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	76.62	3.02	0.81	2.22	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	80.75	2.71	0.34	1.19	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	136.64	5.76	0.09	1.60	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	110.51	1.98	0.31	3.02	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	113.74	2.56	0.00	1.88	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	83.32	2.32	0.22	1.77	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	105.83	3.91	0.25	2.16	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	112.71	3.47	0.41	1.43	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	89.12	2.27	1.65	0.21	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	77.36	2.08	0.23	1.04	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	73.88	2.67	0.17	2.50	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	88.61	1.32	0.44	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	85.73	2.34	0.98	2.21	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	67.59	2.59	0.49	1.62	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	77.61	0.96	0.00	1.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	79.40	1.90	0.57	1.42	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	66.91	2.06	0.32	2.69	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	72.37	1.52	0.91	0.61	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	75.69	2.93	0.52	1.36	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	67.84	1.76	0.00	1.32	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	78.83	1.96	0.56	1.12	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	87.68	3.80	0.65	1.11	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	66.58	1.87	0.53	0.80	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	118.58	8.42	0.77	1.68	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	79.54	5.57	0.91	1.04	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	71.83	1.08	0.27	2.17	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	82.40	2.40	0.55	1.29	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	71.72	2.85	0.22	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	82.31	0.99	0.99	6.94	5.95
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	90.36	5.28	0.13	0.92	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	97.85	6.46	0.61	0.40	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	131.15	1.02	0.25	2.29	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	20.50	4.38	0.00	0.80	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	18.80	4.78	0.15	0.77	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	15.55	3.48	0.20	0.82	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	12.83	0.00	0.00	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	10.45	1.98	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	6.46	2.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	19.73	2.71	0.39	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	33.69	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	0.00	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	16.92	1.30	0.65	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	23.88	1.65	0.41	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	27.41	1.68	0.00	0.28	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.63	0.98	1.31	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	24.33	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	38.49	0.95	0.32	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	44.16	1.02	0.00	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	34.93	2.29	0.57	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	32.85	0.59	0.59	0.59	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	1.69	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	43.49	0.83	0.41	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.23	0.69	0.00	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	0.00	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	31.14	0.00	0.77	1.15	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	42.70	0.65	0.65	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	29.43	0.67	2.01	3.34	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	39.30	0.00	0.77	1.16	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	58.88	3.08	0.68	2.05	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.99	0.00	0.94	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	42.85	0.60	1.81	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	33.06	0.51	1.02	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	33.10	0.40	0.80	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.38	0.00	0.49	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	37.77	0.00	1.18	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	34.42	0.58	1.17	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.01	0.00	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	30.52	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	39.99	1.79	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	27.17	0.97	0.49	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	73.04	4.57	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	102.29	4.99	2.08	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	87.71	2.25	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	120.20	3.81	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	109.45	5.01	2.09	0.42	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	63.13	2.44	0.46	0.46	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	69.04	4.39	0.68	0.34	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	65.98	2.96	0.00	0.46	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	64.93	3.72	0.66	0.11	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	82.10	4.08	0.64	0.00	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	60.71	4.09	0.65	0.00	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	57.41	2.86	0.12	0.50	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	54.21	4.12	0.69	0.51	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	63.11	3.52	0.64	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	34.14	1.68	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	31.59	3.46	0.43	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	27.87	2.82	0.00	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.98	2.18	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	90.39	7.52	1.05	0.35	0.17
Hepatocyte, donor1	11523-119I2	56.90	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	144.36	1.08	3.23	0.00	0.00
Hepatocyte, donor3	11684-122I1	112.89	0.00	0.00	0.00	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	13.05	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	101.37	2.62	0.00	2.10	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	102.08	8.92	0.00	0.82	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	17.44	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.04	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.33	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	15.27	3.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	9.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	10.86	0.47	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	20.45	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	17.28	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.99	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	16.57	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	449.53	122.24	1.63	0.65	0.49
Keratinocyte - epidermal, donor2	11349-117G8	196.77	78.48	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	460.50	222.25	5.21	0.38	0.09
Keratinocyte - oral, donor1	11251-116E9	497.32	49.27	1.36	1.14	0.57
Keratocytes, donor1	11527-119I6	120.68	6.19	0.34	0.34	0.00
Keratocytes, donor2	11607-120I5	43.36	3.52	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	172.30	4.74	1.58	1.38	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	243.97	4.40	2.20	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	69.04	8.63	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	97.92	4.73	0.00	1.73	0.46
Lens Epithelial Cells, donor3	11690-122I7	123.21	3.73	0.20	1.92	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	60.36	1.78	0.71	1.07	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.09	1.67	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	36.68	2.52	0.16	0.63	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	42.48	0.54	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	34.35	2.21	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.12	0.32	0.22	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.12	4.10	2.05	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.56	1.01	0.25	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	26.88	0.84	0.84	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	50.63	2.37	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	42.46	1.94	0.19	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.66	0.56	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	65.16	2.09	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	36.73	2.39	0.48	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	28.29	0.41	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	53.89	2.46	0.31	1.85	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.81	1.25	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.38	0.91	0.18	1.10	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	48.71	1.97	0.66	1.97	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.77	1.46	0.59	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	20.41	0.00	0.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	57.23	3.88	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	43.90	2.96	0.27	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	34.82	1.36	0.00	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	45.10	2.07	0.00	1.04	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	50.25	1.68	0.21	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	23.91	1.50	0.75	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	46.09	1.38	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	40.26	1.69	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	22.69	0.95	0.21	0.42	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	47.49	4.85	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	51.27	2.65	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.92	0.87	0.37	0.62	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.83	1.85	0.74	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	43.98	2.72	0.00	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	21.31	1.24	0.41	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	55.00	1.29	0.96	0.00	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	58.13	2.74	0.61	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.61	0.56	0.28	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	54.76	1.07	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	31.03	0.48	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	17.74	1.09	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	51.21	2.15	0.00	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	40.51	1.31	0.65	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.42	0.71	0.00	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	51.85	1.86	0.37	0.50	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	30.22	1.54	0.77	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.06	1.49	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.84	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.12	0.85	0.00	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	0.00	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.24	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.25	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	19.19	0.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.71	0.45	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.02	0.95	0.00	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.17	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	18.66	0.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.24	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	20.28	1.07	0.00	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	22.48	1.51	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.34	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	19.57	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	21.24	1.04	0.42	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	27.75	1.40	0.84	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.97	0.58	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	28.70	1.79	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.56	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.92	1.41	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	26.92	1.48	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	17.27	1.15	0.38	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.81	1.13	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	23.79	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	20.79	1.36	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	23.70	2.87	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	24.65	1.49	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.18	0.37	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	27.57	0.43	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	1.71	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	23.32	2.00	1.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.74	0.60	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.06	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	22.00	1.03	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.08	1.07	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	11.45	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.00	0.74	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	17.44	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	17.98	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.61	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	17.63	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	0.99	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.55	1.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	19.38	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	15.59	1.34	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	13.69	1.17	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	1.32	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.64	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.00	0.44	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	18.45	2.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.55	1.32	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	20.83	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.28	1.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.07	1.44	1.44	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.47	2.78	0.00	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.95	0.61	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.56	0.76	0.38	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	30.47	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.37	3.63	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	26.94	1.58	0.32	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.99	1.07	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.26	2.30	1.15	0.00	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	27.25	2.06	0.00	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	37.49	3.54	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.94	5.11	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	22.05	1.25	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	32.10	1.57	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	27.98	1.25	1.25	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	29.27	3.72	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	34.12	2.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	44.38	5.35	0.53	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	40.01	0.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.04	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	43.57	1.78	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	40.46	3.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	39.11	2.30	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	35.57	1.64	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	42.32	3.12	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	36.39	2.86	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	29.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	279.65	5.47	1.14	2.51	1.14
Macrophage - monocyte derived, donor2	11313-117C8	114.51	2.39	0.37	1.47	0.37
Macrophage - monocyte derived, donor3	11389-118C3	209.73	8.00	1.57	0.92	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	391.36	47.79	2.12	1.06	1.59
Mallassez-derived cells, donor2	11929-125I3	502.45	33.27	1.58	1.43	0.79
Mallassez-derived cells, donor3	11930-125I4	475.75	50.04	1.39	1.25	0.56
Mammary Epithelial Cell, donor1	11273-116H4	1100.06	127.15	3.49	2.89	0.60
Mammary Epithelial Cell, donor2	11350-117G9	904.84	144.77	5.79	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	224.23	63.10	1.75	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	2116.52	1163.34	4.07	2.03	2.03
Mast cell, donor1	11563-120D6	204.82	10.38	0.22	0.97	0.54
Mast cell, donor2	11565-120D8	444.87	54.09	1.49	4.46	1.49
Mast cell, donor3	11566-120D9	377.98	14.41	0.68	5.63	2.70
Mast cell, donor4	11567-120E1	395.18	46.63	1.24	3.37	2.66
Mast cell, expanded and stimulated, donor5	11940-126A5	269.58	22.95	1.11	1.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	392.82	48.45	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	289.10	14.23	1.95	1.26	0.34
Mast cell, expanded, donor8	11941-126A6	150.46	7.53	1.00	0.67	0.00
Melanocyte - dark, donor1	11502-119F8	63.08	0.99	0.70	0.60	0.40
Melanocyte - dark, donor2	11582-120F7	67.83	1.04	1.38	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	54.11	4.71	0.29	0.65	0.14
Melanocyte - light, donor1	11274-116H5	56.65	5.41	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	27.98	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	56.37	2.60	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	130.47	19.47	0.94	1.35	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	235.06	51.64	2.15	0.81	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	137.68	7.77	0.27	2.95	1.61
Meningeal Cells, donor1	11493-119E8	67.61	5.95	0.25	0.12	0.25
Meningeal Cells, donor2	11573-120E7	71.30	2.20	0.88	0.44	0.88
Meningeal Cells, donor3	11654-122E7	104.49	5.79	0.16	0.41	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	45.91	2.28	0.57	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	338.73	48.20	1.41	2.52	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	2.62	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	56.69	3.59	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	500.62	22.24	1.91	1.91	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	389.05	21.11	2.01	1.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.26	1.76	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.73	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	23.73	0.82	0.41	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	97.92	3.32	0.83	0.42	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	53.90	1.12	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	219.33	3.95	0.53	0.92	1.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	45.70	2.08	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	42.04	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	38.42	3.20	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	86.13	4.25	0.00	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	209.21	5.94	1.56	1.56	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	114.66	13.79	2.18	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	1102.33	1138.66	11.40	6.63	4.24
Mesothelial Cells, donor2	12156-128G5	769.72	331.81	1.50	4.00	2.50
Mesothelial Cells, donor3	11402-118D7	684.71	687.67	6.79	4.70	3.83
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	199.85	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	198.25	5.66	0.25	1.23	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	130.15	2.36	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	138.28	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	165.82	2.79	0.62	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	108.69	2.07	0.41	0.62	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	78.75	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	220.48	3.50	0.00	1.25	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	123.35	6.52	0.93	0.47	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	184.72	3.86	0.20	1.22	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	110.47	3.17	0.00	1.19	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	172.56	3.54	0.88	1.77	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	130.32	2.66	1.52	1.14	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	92.11	2.63	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	181.03	4.03	1.70	1.91	1.91
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	55.25	3.68	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	161.55	8.94	1.19	2.68	1.79
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	70.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	172.12	12.80	0.75	2.26	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	82.71	2.61	0.24	0.71	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	85.70	3.87	0.00	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	165.09	14.28	0.69	2.30	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	74.67	2.94	0.00	0.42	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	125.56	7.13	0.20	1.83	1.83
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	165.20	8.80	0.21	1.72	1.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	68.91	3.11	0.00	0.67	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	153.75	8.10	0.00	1.53	1.53
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	52.22	0.51	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	59.65	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	131.82	9.24	0.54	2.45	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	67.93	3.82	0.59	0.88	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	44.70	3.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	131.67	8.65	0.48	1.44	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	58.83	3.60	0.80	1.60	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	47.99	6.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	144.67	15.52	1.50	2.50	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	57.08	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	112.98	11.39	1.31	2.63	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	35.32	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	33.94	3.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	102.14	8.93	0.50	1.49	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	53.58	3.48	0.00	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	97.09	5.13	0.68	2.05	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	35.45	3.06	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	42.26	2.13	0.36	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	80.52	5.33	0.00	1.68	3.37
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	37.82	2.08	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.97	2.91	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	66.97	5.13	0.60	1.21	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	58.85	4.59	0.42	1.25	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	57.26	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	52.36	5.12	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	58.17	3.59	0.28	1.52	1.66
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	65.56	4.66	0.00	1.30	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	59.20	4.29	0.00	2.14	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	45.73	1.27	0.00	0.64	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	48.57	4.54	0.00	2.67	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	98.18	6.29	0.00	1.50	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	52.12	3.25	0.14	1.27	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	69.75	3.19	0.00	2.55	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	63.46	2.87	0.00	1.99	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	43.99	1.52	0.76	1.52	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	56.54	1.70	0.00	2.56	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	66.37	3.20	0.25	0.25	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	52.13	2.61	0.00	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	59.69	2.35	0.29	0.88	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	91.40	6.63	1.15	0.29	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	138.07	2.89	0.41	0.41	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	86.06	4.76	0.00	2.68	2.38
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	229.78	0.00	7.53	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	247.73	1.78	0.00	3.56	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	281.59	6.90	1.64	2.63	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	143.07	4.21	1.05	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	203.62	2.37	1.38	8.50	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	239.35	1.86	1.86	8.38	4.66
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	233.95	3.38	1.50	4.88	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	117.99	0.80	0.27	2.66	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	273.59	5.99	0.57	4.98	1.58
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	140.71	3.68	0.74	4.42	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	251.37	4.40	2.56	1.83	3.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	141.56	1.56	7.78	4.67	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	303.03	4.81	1.07	4.81	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	108.19	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	180.78	0.00	3.03	1.01	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	136.19	2.95	0.00	0.42	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	276.47	8.17	0.00	4.09	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	214.90	6.99	0.64	5.72	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	271.30	8.10	1.62	3.24	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	131.41	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	228.41	22.84	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	192.48	6.52	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	123.56	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	150.59	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	154.04	5.60	0.65	0.65	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	47.56	0.52	0.00	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	91.45	8.01	0.67	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	38.40	5.01	0.42	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	57.42	3.61	0.76	0.00	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	178.74	9.58	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	53.04	8.16	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	42.27	9.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	49.81	4.60	1.26	1.26	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	57.64	6.04	0.46	0.46	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	51.88	5.40	0.27	0.27	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	71.06	4.84	0.00	0.42	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	54.10	2.98	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	46.01	4.60	0.81	1.35	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	67.78	6.57	1.13	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	33.15	5.39	0.98	0.82	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	78.92	5.65	2.19	0.91	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	78.50	10.08	0.53	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	46.22	6.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	39.71	3.61	0.33	0.98	2.30
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	60.33	7.64	0.65	0.81	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	91.54	9.35	0.53	0.71	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	56.96	5.63	1.41	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	44.59	8.27	1.38	0.46	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	69.73	8.03	1.29	2.25	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	75.19	8.28	2.76	1.38	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	40.46	12.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	81.76	8.69	0.89	1.11	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	58.43	10.58	1.69	0.85	2.12
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	47.23	5.46	0.24	1.19	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	77.26	10.30	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	9.03	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	73.31	7.66	1.00	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	81.61	12.17	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	88.49	11.11	2.38	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	71.51	3.71	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	72.65	7.57	2.65	3.03	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	108.52	5.21	1.96	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	66.24	10.89	0.87	1.74	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	102.67	10.85	0.00	1.36	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	136.70	7.94	2.65	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	55.85	7.31	1.33	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	83.34	2.98	1.49	1.98	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	89.96	7.66	1.91	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	162.41	12.40	0.30	1.51	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	120.46	7.51	1.33	0.44	1.99
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	107.75	8.13	1.36	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	5.11	5.11	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	86.57	4.27	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	88.13	6.61	0.94	0.31	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	70.82	9.08	1.51	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	97.31	2.37	1.58	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	112.23	11.34	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	101.00	4.22	1.37	0.00	0.12
Myoblast, donor2	11322-117D8	51.97	3.07	0.19	0.00	0.38
Myoblast, donor3	11398-118D3	78.53	5.38	0.84	1.01	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	175.27	10.51	0.73	0.44	0.00
Natural Killer Cells, donor1	11230-116C6	297.06	4.61	0.62	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	234.91	6.03	0.90	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	213.13	2.58	0.92	0.74	0.37
Neural stem cells, donor1	11275-116H6	172.76	3.27	0.00	2.90	1.09
Neural stem cells, donor2	11352-117H2	154.05	1.93	0.00	1.93	1.93
Neurons, donor1	11494-119E9	109.24	9.10	1.14	0.00	2.28
Neurons, donor2	11574-120E8	89.83	3.30	0.44	1.32	0.00
Neurons, donor3	11655-122E8	65.77	4.11	3.29	0.00	0.82
Neutrophils, donor1	11233-116C9	11.14	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	21.38	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	77.18	4.51	0.12	1.78	1.66
Nucleus Pulposus Cell, donor2	11409-118E5	31.58	0.98	0.98	0.33	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	58.16	4.61	0.40	0.40	0.80
Olfactory epithelial cells, donor1	11933-125I7	157.20	8.12	1.93	1.79	1.51
Olfactory epithelial cells, donor2	11934-125I8	208.29	11.72	6.08	0.58	0.58
Olfactory epithelial cells, donor3	11935-125I9	281.83	18.61	2.72	0.91	0.11
Olfactory epithelial cells, donor4	11936-126A1	317.03	17.24	1.17	0.49	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	89.07	3.01	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	110.81	4.89	0.43	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	74.30	3.43	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	76.97	5.59	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	29.32	1.56	0.39	0.59	0.00
Osteoblast, donor2	11354-117H4	120.10	14.75	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	55.81	4.62	0.18	0.00	0.36
Pancreatic stromal cells, donor1	11249-116E7	208.06	10.78	1.85	1.10	0.93
Pericytes, donor1	11491-119E6	18.36	0.56	0.11	0.33	0.22
Pericytes, donor2	11571-120E5	17.20	0.68	0.45	0.23	0.45
Pericytes, donor3	11652-122E5	74.67	4.88	0.81	0.20	0.20
Perineurial Cells, donor1	11499-119F5	185.81	10.85	0.23	0.90	0.34
Perineurial Cells, donor2	11579-120F4	71.77	2.67	0.83	0.64	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	205.91	1.27	0.00	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	141.78	2.69	0.98	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	194.38	2.98	0.65	0.26	0.13
Placental Epithelial Cells, donor1	11278-116H9	49.51	2.15	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	48.79	3.33	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	35.73	1.37	0.79	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	174.68	3.80	4.43	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	189.84	7.50	0.56	0.38	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	111.99	5.22	0.78	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	152.65	3.83	0.45	2.03	0.45
Preadipocyte - omental, donor1	11468-119C1	317.44	12.89	1.28	1.17	1.07
Preadipocyte - omental, donor2	11329-117E6	192.48	6.55	0.44	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	145.97	7.31	1.00	0.72	1.00
Preadipocyte - perirenal, donor1	11469-119C2	115.16	1.97	0.98	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	200.55	13.21	0.00	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	120.41	5.14	0.71	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	330.69	29.80	1.53	1.02	1.02
Preadipocyte - visceral, donor1	11280-116I2	214.89	14.34	0.37	0.75	0.56
Preadipocyte - visceral, donor2	11357-117H7	330.41	26.23	2.30	1.84	0.92
Preadipocyte - visceral, donor3	11429-118G7	130.51	9.09	0.94	0.21	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	91.72	2.11	1.06	2.26	0.75
Prostate Epithelial Cells, donor2	11331-117E8	360.06	39.54	3.66	0.95	0.41
Prostate Epithelial Cells, donor3	11404-118D9	402.88	166.99	4.90	0.43	0.12
Prostate Stromal Cells, donor1	11254-116F3	425.99	34.85	3.19	2.28	1.14
Prostate Stromal Cells, donor2	11332-117E9	122.64	8.96	0.36	0.72	0.36
Prostate Stromal Cells, donor3	11405-118E1	299.38	13.97	5.63	2.82	2.19
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.02	1.09	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	78.46	1.94	0.42	0.76	0.69
Renal Epithelial Cells, donor1	11517-119H5	15.72	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	25.61	0.71	0.00	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	117.09	3.07	0.32	0.85	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	27.91	1.36	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	46.49	3.50	0.00	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	72.38	2.22	0.00	0.00	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	14.64	0.67	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	33.23	0.66	0.00	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	25.08	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	10.26	1.66	0.00	0.55	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	51.27	1.88	0.00	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	27.83	0.84	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	24.11	1.16	0.39	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	141.57	6.48	0.52	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	66.23	1.71	0.28	0.57	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	11.32	3.09	0.00	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	272.74	9.03	0.75	1.00	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	141.25	5.35	0.67	1.20	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	77.73	0.00	0.00	3.57	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	93.01	2.20	0.55	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	70.77	0.58	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	79.45	2.99	0.26	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	71.60	2.58	0.79	0.20	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	91.02	1.56	0.45	0.56	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	80.38	2.85	0.62	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	80.18	4.08	0.58	0.35	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	74.66	1.85	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	61.61	1.51	0.55	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	66.71	1.97	0.45	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	74.01	0.54	0.18	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	65.70	2.44	0.00	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	76.30	3.22	0.21	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	58.42	2.88	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	64.04	2.49	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	70.80	1.86	0.28	0.19	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	103.91	3.01	0.75	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	69.67	2.12	0.53	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	69.40	2.34	0.19	0.10	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	69.32	3.44	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	68.56	2.35	0.11	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	72.60	2.52	0.28	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	71.61	1.20	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	57.80	2.19	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	74.07	2.82	0.37	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	69.85	1.48	0.13	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	82.08	2.36	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	66.87	2.18	0.20	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	74.83	3.04	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	75.68	2.70	0.83	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	86.71	2.88	0.66	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	59.95	2.51	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	78.87	2.56	0.54	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	66.24	2.72	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	58.61	1.74	0.39	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	57.94	1.55	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	58.02	1.37	0.27	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	53.68	1.31	0.49	0.82	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	53.00	2.05	0.34	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	60.07	1.92	0.00	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	52.51	0.53	0.53	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	92.09	2.21	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	56.67	1.19	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	71.95	1.41	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	66.30	1.41	0.00	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	95.03	0.35	0.35	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	81.30	1.51	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	58.87	1.35	0.12	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	165.20	1.16	0.58	0.29	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	105.26	3.65	0.00	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	61.79	1.21	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	140.01	2.04	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	105.44	2.40	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	142.04	1.77	0.59	0.24	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	112.06	2.77	0.43	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	84.14	0.60	0.00	0.00	1.20
Schwann Cells, donor1	11498-119F4	16.74	2.26	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	78.26	10.21	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	65.94	3.94	1.31	0.22	0.22
Sebocyte, donor1	11220-116B5	407.54	65.73	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	209.56	50.55	1.38	0.00	0.00
Sebocyte, donor3	11378-118B1	95.43	39.78	0.00	0.62	0.00
Sertoli Cells, donor1	11255-116F4	218.67	16.57	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	197.71	16.95	8.47	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	132.41	11.35	0.79	1.14	0.35
Skeletal Muscle Cells, donor2	11358-117H8	39.03	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	54.34	20.06	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	50.11	3.61	0.63	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	39.09	4.01	0.15	0.00	0.30
Skeletal Muscle Cells, donor6	11459-119B1	50.79	5.69	0.15	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	46.24	3.40	0.13	0.88	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.82	1.14	0.57	0.43	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	57.64	6.65	0.40	0.40	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	87.62	5.31	0.51	1.18	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	49.94	13.03	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	34.12	2.06	0.00	0.14	0.14
Skin - palm, donor1	10286-104F7	24.17	8.06	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	166.21	11.68	2.31	0.14	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	131.68	10.63	0.82	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	132.94	10.39	1.69	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	623.73	40.59	3.34	1.53	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	418.45	34.32	1.13	1.41	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	327.95	24.53	0.85	0.85	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	547.44	69.70	3.07	0.52	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	41.66	4.32	1.54	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1005.16	79.15	4.22	2.22	1.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	149.31	11.76	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	56.35	5.30	0.66	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	118.53	11.42	0.39	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	169.96	10.04	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	177.13	2.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	67.47	3.86	0.40	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	243.60	14.19	2.22	0.89	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	95.51	9.99	0.38	0.26	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	61.54	2.93	0.33	1.63	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	81.81	5.91	1.18	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	110.33	9.25	0.28	1.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.12	3.42	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	117.82	6.39	1.52	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	377.83	56.32	1.26	0.76	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	31.47	4.77	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	122.85	10.32	0.88	1.03	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	80.07	5.17	0.86	0.22	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	72.95	4.62	0.63	0.31	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	109.51	12.37	0.15	0.62	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	59.28	4.31	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	106.09	20.62	0.90	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	17.07	1.71	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	88.97	5.58	0.31	1.02	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	251.20	12.38	1.11	2.21	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	832.16	148.82	7.51	2.05	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	233.67	35.02	3.62	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	88.75	5.30	0.53	1.06	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	318.25	9.85	0.93	0.27	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	296.77	24.42	2.13	1.00	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	134.95	4.57	0.76	1.78	2.28
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	336.83	26.39	1.66	1.36	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	225.05	43.51	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	36.18	2.58	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	215.79	43.72	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	110.06	10.10	0.00	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	162.34	14.73	1.57	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	31.27	0.88	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	80.14	6.91	0.25	0.67	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	53.72	3.74	0.47	3.74	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	126.22	8.49	0.00	0.29	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	48.44	10.20	0.76	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	36.29	2.07	0.56	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	154.14	14.39	0.28	1.12	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	184.75	10.05	0.34	1.68	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	29.52	6.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	130.89	8.32	0.24	0.73	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	342.47	21.21	1.33	1.33	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	96.55	4.68	0.59	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	184.25	5.83	0.58	2.33	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	135.40	3.17	0.53	1.06	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	374.55	4.84	3.72	2.23	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	998.60	89.47	10.42	5.39	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	176.30	9.65	0.28	1.70	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	112.65	5.51	1.18	0.79	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	403.28	11.43	3.56	2.54	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	144.95	3.99	1.20	1.60	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	153.83	5.85	2.51	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	95.80	4.13	0.46	0.92	1.38
Synoviocyte, donor1	11291-117A4	151.83	6.56	0.67	0.50	0.17
Synoviocyte, donor2	11368-117I9	158.24	10.73	1.51	0.84	0.67
Synoviocyte, donor3	11440-118H9	133.38	6.48	1.79	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	56.46	6.43	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	81.26	7.93	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	40.06	3.70	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	251.11	46.24	0.86	0.22	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	89.68	18.17	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	105.37	10.31	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	145.91	4.18	0.12	1.11	0.74
Urethra, donor2	10319-105A4	106.11	7.19	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	138.94	15.67	0.80	1.33	0.00
Urothelial Cells, donor2	11600-120H7	92.93	11.62	1.20	1.20	0.00
Urothelial Cells, donor3	11681-122H7	77.24	8.94	0.92	0.00	0.00
Urothelial cells, donor0	11216-116B1	514.44	37.45	1.11	1.78	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	144.14	1.78	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	147.25	5.72	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	72.56	2.05	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	90.91	1.38	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	98.77	0.58	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	127.03	3.12	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	111.97	0.92	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	81.25	1.83	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	52.68	0.00	0.74	0.99	1.85
Wilms' tumor cell line:HFWT	10597-108E3	118.81	14.08	0.00	0.00	4.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	225.41	8.94	0.56	0.28	0.00
achilles tendon, donor2	10292-104G4	66.13	59.93	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	11.98	0.76	0.00	0.76	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	67.79	0.23	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	65.29	2.26	0.00	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	47.35	0.00	0.27	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	33.17	0.56	0.00	0.28	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	8.67	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.27	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	28.64	2.20	0.00	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	43.69	0.41	1.23	1.23	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	62.90	2.33	0.00	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.06	0.18	0.37	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.23	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	67.83	5.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	48.51	0.29	0.88	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	53.91	1.39	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	46.88	1.23	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.68	0.31	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	14.08	0.00	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	14.56	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	11.55	0.48	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	42.99	0.67	0.00	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	4.14	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	114.34	5.62	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	124.56	2.33	0.47	0.62	0.16
adipose, donor1	10184-103D4	4.10	0.00	0.00	0.00	0.59
adipose, donor2	10185-103D5	4.06	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	16.34	0.27	0.27	0.27	0.27
adipose, donor4	10187-103D7	6.07	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	25.72	1.89	0.00	0.95	0.47
adrenal gland, adult, pool1	10081-102A9	50.93	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	65.90	2.27	0.13	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	238.32	12.15	1.43	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	88.10	2.78	0.00	1.16	0.00
amniotic membrane cells, donor2	12236-129G4	70.66	0.00	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	74.53	1.47	0.29	0.00	0.29
amygdala - adult, donor10196	10167-103B5	1215.44	5.93	14.23	4.74	2.37
amygdala, adult, donor10252	10151-102I7	796.06	6.89	2.84	1.62	1.01
amygdala, newborn, donor10223	10360-105E9	359.24	14.85	2.90	1.94	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	359.45	120.45	1.53	3.57	2.42
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	66.63	6.40	0.22	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	4.01	0.33	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	192.60	6.28	2.16	0.39	0.20
appendix, adult	10189-103D9	88.49	5.82	0.39	1.55	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	49.53	0.00	0.69	0.69	0.00
artery, adult	10190-103E1	116.85	5.43	0.00	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	189.20	17.82	0.72	2.03	2.46
b cell line:RPMI1788	10427-106D4	14.72	1.04	0.00	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	259.41	15.54	4.16	1.66	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	244.61	20.04	0.69	0.99	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	135.91	18.75	0.00	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.91	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	253.35	8.15	0.87	1.30	1.20
blood, adult, pool1	10053-101G8	57.58	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	37.68	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	166.01	4.72	2.02	0.67	2.02
brain, adult, donor1	10084-102B3	569.94	12.30	10.25	0.00	1.03
brain, adult, pool1	10012-101C3	982.18	10.47	4.23	4.68	2.56
brain, fetal, pool1	10085-102B4	216.38	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	54.51	2.31	0.00	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	15.48	0.12	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	81.44	2.53	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	298.03	17.15	1.52	4.19	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	142.55	2.16	0.00	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	155.40	10.82	4.60	4.83	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	28.81	0.73	0.48	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	6.58	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	273.34	10.94	1.09	0.66	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	69.72	1.90	0.00	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	93.43	2.13	1.06	2.40	3.46
caudate nucleus - adult, donor10196	10177-103C6	735.70	16.12	3.45	4.61	8.06
caudate nucleus, adult, donor10252	10164-103B2	644.71	13.22	2.01	2.01	1.84
caudate nucleus, adult, donor10258	10379-105H1	816.86	8.41	5.35	6.11	4.58
caudate nucleus, newborn, donor10223	10354-105E3	276.14	20.51	1.10	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	1267.27	5.83	2.91	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	1163.63	16.87	3.84	0.64	0.64
cerebellum, adult, pool1	10083-102B2	573.99	11.04	10.35	1.03	1.72
cerebellum, newborn, donor10223	10357-105E6	374.46	6.64	1.66	1.66	0.83
cerebral meninges, adult	10188-103D8	779.87	15.88	4.29	3.53	1.76
cerebrospinal fluid, donor2	10294-104G6	75.28	5.12	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	247.88	10.21	0.29	1.01	0.14
cervical cancer cell line:ME-180	10553-107I4	767.76	99.76	2.49	0.99	0.17
cervix, adult, pool1	10013-101C4	267.20	9.76	1.36	3.88	1.68
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	1023.44	253.46	6.55	3.07	1.53
chondrosarcoma cell line:SW 1353	10700-109G7	104.50	19.59	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	45.24	1.74	0.12	1.12	0.25
choriocarcinoma cell line:SCH	10785-110H2	40.41	0.86	0.12	1.11	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	23.01	0.24	0.00	0.47	0.71
chorionic membrane cells, donor1	12238-129G6	54.70	5.13	1.14	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	98.64	2.88	0.40	0.70	0.30
chorionic membrane cells, donor3	12240-129G8	56.60	2.75	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	52.51	0.00	3.03	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	42.07	1.34	0.00	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	32.52	0.63	0.21	0.63	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.37	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	30.23	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.23	0.61	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	30.62	0.29	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	48.22	2.35	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	75.20	1.60	0.46	1.14	2.97
clear cell carcinoma cell line:TEN	10636-108I6	129.26	6.59	1.74	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	14.46	0.18	0.00	0.55	0.37
colon carcinoma cell line:COLO-320	10420-106C6	53.59	0.38	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	123.76	16.66	5.95	1.19	0.00
colon, adult, pool1	10014-101C5	244.88	9.99	0.35	0.47	0.59
colon, fetal, donor1	10070-101I7	79.72	6.18	1.85	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	22.92	4.58	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	79.89	4.67	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	62.18	2.41	0.30	0.60	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	51.19	1.83	0.00	0.85	0.42
corpus callosum, adult, pool1	10042-101F6	1054.99	10.50	1.77	4.53	3.21
cruciate ligament, donor2	10295-104G7	66.46	7.29	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	48.96	2.41	0.00	1.61	0.00
diencephalon, adult	10193-103E4	629.73	9.84	2.40	3.84	2.88
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	51.89	0.69	0.69	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	406.71	28.46	1.28	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	806.18	159.36	4.57	3.61	0.72
ductus deferens, adult	10196-103E7	116.11	1.00	2.49	1.99	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	51.85	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	122.12	2.21	1.47	0.00	0.74
dura mater, adult, donor1	10041-101F5	196.89	8.26	0.17	0.91	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	56.85	8.88	0.67	0.44	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	54.16	1.72	0.29	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	585.17	55.50	2.47	1.23	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	256.40	33.60	3.33	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	643.13	55.27	1.23	1.23	0.62
embryonic pancreas cell line:2C6	10603-108E9	583.18	55.17	3.94	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	140.45	10.73	2.01	2.68	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	397.27	88.08	3.08	1.99	2.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.98	0.96	0.32	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	573.47	119.94	0.89	1.67	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	323.91	85.02	0.66	1.10	0.55
epididymis, adult	10197-103E8	126.21	4.40	0.63	0.84	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	56.24	3.73	0.35	1.60	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	146.29	8.26	0.39	1.97	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	51.76	4.46	0.26	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	80.02	7.09	0.30	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	60.16	5.38	0.00	0.22	0.11
esophagus, adult, pool1	10015-101C6	184.32	5.42	0.85	0.74	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	570.20	8.02	1.00	3.51	3.63
eye - muscle inferior rectus, donor1	10272-104E2	55.54	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	58.92	2.10	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	58.04	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	102.04	13.76	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	74.33	8.74	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	287.28	3.31	3.31	1.02	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	312.61	77.96	1.03	0.77	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	142.69	13.30	1.19	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	1326.20	20.92	1.97	4.13	3.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	113.49	5.10	0.90	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	121.70	12.25	0.37	0.73	0.18
gall bladder, adult	10198-103E9	176.00	5.79	1.21	1.45	0.97
gamma delta positive T cells, donor1	11937-126A2	175.01	3.22	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	127.36	5.60	0.75	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	128.42	4.86	1.06	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	207.15	10.25	1.16	0.58	0.39
gastric cancer cell line:AZ521	10549-107H9	83.29	0.98	0.16	0.98	0.16
gastric cancer cell line:GSS	10560-108A2	109.83	0.00	0.92	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	2.74	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	121.62	26.39	1.26	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	275.30	8.54	0.56	1.68	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	75.32	9.23	0.75	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	221.55	15.73	0.53	0.42	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	195.77	14.75	0.42	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	504.63	17.22	1.43	0.99	0.55
glioma cell line:GI-1	10413-106B8	115.39	13.18	0.59	0.88	0.59
globus pallidus - adult, donor10196	10175-103C4	518.99	5.83	2.19	1.46	2.19
globus pallidus, adult, donor10252	10161-103A8	636.84	4.39	2.20	1.46	0.73
globus pallidus, adult, donor10258	10367-105F7	444.99	1.37	2.74	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	231.82	17.05	1.07	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	61.18	2.45	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	95.68	6.08	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	35.81	1.38	0.00	0.46	1.84
hIPS +CCl2, biol_rep2	14384-156C1	55.33	0.46	0.91	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	38.00	2.58	0.64	0.64	0.64
hIPS, biol_rep1	14380-156B6	21.56	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	19.20	0.69	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	653.25	4.41	1.10	4.41	7.72
hairy cell leukemia cell line:Mo	10712-109I1	21.26	2.59	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	268.47	11.96	1.79	2.39	0.30
heart - pulmonic valve, adult	10206-103F8	259.38	3.40	0.78	0.78	1.31
heart - tricuspid valve, adult	10207-103F9	106.58	19.98	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	78.36	2.04	0.82	0.41	0.41
heart, adult, diseased, donor1	10051-101G6	142.23	1.28	2.13	0.00	0.00
heart, adult, pool1	10016-101C7	257.80	3.45	0.46	1.61	0.23
heart, fetal, pool1	10046-101G1	433.10	11.91	0.82	2.67	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	163.83	3.70	0.31	0.31	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	135.57	1.19	0.00	0.00	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	189.72	3.20	0.88	0.99	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	177.81	2.91	1.34	0.85	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	220.40	4.35	1.21	2.02	1.82
hepatoma cell line:Li-7	10484-107A7	125.01	2.22	0.22	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.14	0.80	0.20	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	838.45	8.52	4.73	0.95	4.73
hippocampus, adult, donor10252	10153-102I9	870.49	6.94	4.69	1.43	2.65
hippocampus, adult, donor10258	10374-105G5	1199.06	11.45	4.48	1.00	1.99
hippocampus, newborn, donor10223	10363-105F3	295.02	11.63	2.82	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	15.26	1.83	0.61	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	11.39	5.11	0.39	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.16	2.03	0.00	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	7.33	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	7.49	0.00	0.77	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.93	0.00	0.76	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	14.01	0.00	0.00	0.88	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	13.14	0.22	0.22	0.22	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	19.19	0.42	0.00	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	22.50	0.95	0.00	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	19.29	1.13	0.00	0.48	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	23.57	0.00	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	12.21	5.48	0.31	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	10.81	3.44	1.47	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.96	5.24	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.02	0.00	0.19	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6.98	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	3.50	0.00	0.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	9.23	0.19	0.00	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.91	0.00	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	7.52	0.00	0.63	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.56	0.16	0.33	0.16	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.68	0.58	0.29	0.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.63	1.20	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.41	2.96	0.18	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.12	2.57	0.29	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	21.23	2.86	0.41	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	10.56	0.35	0.70	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	10.77	0.00	0.32	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.43	0.00	0.00	0.91	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	16.03	0.00	0.00	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	21.92	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	18.73	0.26	0.26	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	42.69	0.77	0.77	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	44.68	0.76	1.51	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	27.56	1.01	0.00	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	15.21	3.14	0.24	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	17.38	1.78	0.45	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.78	1.46	0.00	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	11.00	0.00	0.61	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	10.59	0.33	0.00	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	9.30	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.84	0.36	0.00	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	13.52	0.00	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	0.00	0.00	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	27.09	0.54	0.14	0.95	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.82	0.00	0.81	0.81	0.54
immature langerhans cells, donor1	11904-125F5	54.97	6.05	0.24	0.24	0.48
immature langerhans cells, donor2	11905-125F6	67.33	7.13	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	1342.00	22.33	2.93	3.60	2.65
keratoacanthoma cell line:HKA-1	10791-110H8	342.71	28.94	1.30	0.65	0.00
kidney, adult, pool1	10017-101C8	145.89	4.51	0.40	1.70	1.30
kidney, fetal, pool1	10045-101F9	75.19	1.41	0.07	0.78	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	283.90	14.77	0.28	1.56	2.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	129.26	9.68	1.52	0.55	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	243.50	44.77	0.00	0.37	0.37
left atrium, adult, donor1	10079-102A7	166.72	1.63	2.18	1.09	0.00
left ventricle, adult, donor1	10078-102A6	115.79	3.54	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	18.88	0.00	0.00	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	303.21	23.71	6.47	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	874.46	153.26	19.02	2.17	1.09
leiomyoma cell line:15425	10571-108B4	337.76	30.84	7.77	2.43	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	203.18	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	88.87	4.18	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	292.55	29.99	0.35	0.71	0.71
liposarcoma cell line:KMLS-1	10782-110G8	254.62	15.62	1.41	1.25	0.94
liposarcoma cell line:SW 872	10726-110A6	461.16	32.77	1.83	2.31	1.34
liver, adult, pool1	10018-101C9	138.89	1.62	0.00	0.49	0.00
liver, fetal, pool1	10086-102B5	51.74	1.88	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	476.12	7.15	1.46	2.77	2.48
locus coeruleus, adult, donor10252	10165-103B3	511.57	12.00	1.48	0.74	1.11
locus coeruleus, adult, donor10258	10375-105G6	498.54	9.59	3.39	2.26	2.26
locus coeruleus, newborn, donor10223	10362-105F2	294.85	10.94	0.84	1.68	1.26
lung adenocarcinoma cell line:A549	10499-107C4	215.62	13.42	0.42	0.55	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	112.37	5.52	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	60.77	2.90	0.40	0.13	0.13
lung, adult, pool1	10019-101D1	154.16	5.91	0.35	0.95	0.24
lung, fetal, donor1	10068-101I5	258.58	3.71	0.00	2.28	1.14
lung, right lower lobe, adult, donor1	10075-102A3	70.57	0.92	2.75	1.83	0.46
lymph node, adult, donor1	10077-102A5	66.27	0.47	1.42	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	39.89	0.66	0.00	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	25.66	1.21	0.45	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	678.75	52.67	3.40	2.55	0.00
mature adipocyte, donor1	12231-129F8	65.71	4.44	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	70.56	4.15	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	104.31	22.76	0.00	0.24	0.24
mature adipocyte, donor4	12234-129G2	102.39	10.27	0.00	1.05	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	151.29	4.77	0.00	1.43	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	1046.81	22.56	2.26	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	884.59	11.40	2.57	1.29	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	633.15	6.04	5.40	1.59	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	382.13	9.81	2.99	1.71	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	1070.39	12.15	42.53	3.38	3.54
medial temporal gyrus, adult, donor10252	10156-103A3	820.88	5.73	4.67	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1298.30	5.78	11.56	0.00	7.71
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	559.79	0.00	57.41	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	378.67	12.92	1.08	2.87	3.23
medulla oblongata - adult, donor10196	10174-103C3	662.61	61.00	3.89	1.95	2.60
medulla oblongata, adult, donor10252	10155-103A2	681.14	11.15	1.55	1.08	0.62
medulla oblongata, adult, pool1	10038-101F2	718.73	11.43	1.88	4.90	2.61
medulla oblongata, newborn, donor10223	10361-105F1	420.78	16.32	2.08	2.43	3.82
medulloblastoma cell line:D283 Med	10838-111E1	461.42	7.97	1.33	1.99	1.55
medulloblastoma cell line:ONS-76	10759-110E3	314.61	33.75	0.61	0.24	0.49
melanoma cell line:COLO 679	10514-107E1	368.42	45.14	1.44	3.31	1.29
melanoma cell line:G-361	10465-106H6	182.42	16.56	2.44	0.81	1.09
meningioma cell line:HKBMM	10691-109F7	241.15	32.38	3.08	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	14.98	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	1.04	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	81.63	5.83	0.77	0.15	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	88.71	6.18	0.18	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	230.24	17.39	1.66	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	74.17	7.73	0.14	0.28	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	91.86	5.58	1.54	0.58	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	124.24	9.02	0.69	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	1054.87	412.61	8.41	3.60	3.95
mesenchymal precursor cell - cardiac, donor2	11753-123G7	360.00	72.80	4.26	0.69	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	123.49	14.72	0.93	0.66	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	58.74	12.42	1.76	0.81	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	228.76	53.49	1.56	1.56	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	580.32	68.18	0.66	2.63	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	124.81	21.72	0.83	0.83	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	401.45	59.69	1.40	1.75	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	720.70	177.62	11.02	2.25	2.25
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	241.19	25.16	1.08	2.52	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	330.73	170.49	3.93	1.86	1.97
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	771.52	353.62	5.93	6.38	2.96
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	454.80	216.07	8.39	2.10	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	141.22	16.44	1.49	0.45	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	285.61	75.36	2.28	1.23	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	480.08	137.69	3.68	1.10	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	285.58	35.77	2.00	1.14	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	63.57	2.11	1.26	0.00	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	86.77	7.31	0.91	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	76.99	5.12	1.02	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	93.97	4.71	1.31	0.52	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	91.19	6.78	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	86.85	4.47	0.47	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	87.66	8.46	1.35	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	77.42	2.75	0.79	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	73.68	3.24	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	95.75	6.06	1.15	0.87	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	95.49	6.47	1.12	0.45	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	87.25	4.33	1.44	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	91.67	4.40	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	73.84	6.71	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	90.06	6.55	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	90.64	6.01	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	87.80	15.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	89.64	6.17	0.97	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	69.84	4.36	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	91.16	5.33	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	77.69	3.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	84.74	2.33	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	82.46	9.93	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	70.56	4.15	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	108.44	3.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	79.17	3.17	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	74.84	3.10	1.38	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	85.97	0.00	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	71.85	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	72.94	3.67	1.22	1.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	93.74	3.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	68.97	1.77	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	67.95	1.56	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	78.86	0.00	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	55.59	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	100.15	2.57	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	88.80	2.75	1.38	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	91.54	1.98	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	90.84	0.00	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	78.87	1.91	3.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	109.61	1.61	1.21	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	85.04	2.18	2.18	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	78.56	1.27	1.27	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	197.24	6.07	0.61	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	266.62	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	199.33	3.29	2.47	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	115.88	1.98	1.98	0.60	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	124.93	1.30	0.00	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	139.55	2.04	0.00	0.00	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	126.12	4.64	0.00	3.09	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	167.73	10.63	0.94	1.42	2.83
mesothelioma cell line:ACC-MESO-4	10494-107B8	205.26	19.69	0.93	3.24	2.32
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	188.04	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	165.43	9.04	1.34	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	92.14	7.49	0.91	0.91	0.45
mesothelioma cell line:Mero-41	10851-111F5	204.38	11.00	2.69	0.49	1.22
mesothelioma cell line:Mero-48a	10852-111F6	81.27	3.76	0.22	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	249.40	14.45	4.47	0.53	0.79
mesothelioma cell line:Mero-83	10854-111F8	147.75	8.17	1.87	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	108.95	13.14	1.01	0.76	1.01
mesothelioma cell line:Mero-95	10856-111G1	211.39	22.15	1.86	2.69	2.28
mesothelioma cell line:NCI-H2052	10847-111F1	299.49	22.03	2.15	1.49	2.15
mesothelioma cell line:NCI-H226	10846-111E9	122.71	8.33	0.72	0.36	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	247.01	11.10	1.37	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	27.99	1.02	1.02	0.00	0.25
mesothelioma cell line:No36	10857-111G2	242.04	10.11	0.65	1.30	0.65
mesothelioma cell line:ONE58	10858-111G3	135.48	2.44	0.81	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	15.74	0.19	0.19	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	15.39	0.85	0.24	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	14.90	0.36	0.00	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	250.74	16.00	4.57	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	141.57	48.96	4.03	0.42	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	222.76	22.58	0.00	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.32	0.76	0.00	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.06	3.33	0.18	0.00	0.00
myeloma cell line:PCM6	10474-106I6	150.03	6.52	0.59	0.40	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	488.01	62.90	0.00	1.52	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	58.45	11.96	0.20	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	580.97	250.71	2.90	1.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	544.05	200.99	2.57	0.88	0.15
nasal epithelial cells, donor2	12227-129F4	480.78	70.10	1.66	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	39.34	0.00	0.00	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	69.97	0.94	0.19	1.12	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	190.85	2.32	0.00	0.63	0.84
neuroblastoma cell line:NH-12	10555-107I6	38.95	0.93	0.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	112.92	0.71	1.19	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	200.83	7.92	1.43	0.48	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	75.67	2.62	0.40	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	106.17	3.81	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	99.81	5.06	1.06	0.00	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	39.24	1.35	0.00	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	45.63	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	169.28	6.41	5.77	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	365.24	18.13	3.42	1.84	1.05
nucleus accumbens, adult, pool1	10037-101F1	1108.00	17.72	1.87	4.41	2.91
occipital cortex - adult, donor10196	10172-103C1	918.93	14.42	0.00	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	685.13	7.25	3.49	1.34	1.61
occipital cortex, newborn, donor10223	10355-105E4	488.41	10.92	0.00	1.09	1.82
occipital lobe, adult, donor1	10076-102A4	664.13	13.12	7.35	2.10	2.89
occipital lobe, fetal, donor1	10073-102A1	139.03	3.00	0.00	0.00	0.43
occipital pole, adult, pool1	10036-101E9	903.21	13.95	1.02	3.55	1.97
olfactory region, adult	10195-103E6	824.96	10.89	4.39	1.72	2.10
optic nerve, donor1	10277-104E7	432.23	4.00	4.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	365.87	40.44	0.91	0.57	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	317.64	26.65	0.69	0.69	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	587.05	49.27	4.57	1.86	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	207.68	6.93	0.92	0.92	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	137.58	12.64	0.59	0.59	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	253.20	55.13	0.93	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	125.96	2.12	0.00	1.06	0.42
ovary, adult, pool1	10020-101D2	182.48	10.48	0.70	3.67	2.80
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	120.99	15.22	1.28	0.18	0.37
pancreas, adult, donor1	10049-101G4	68.67	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	27.39	0.84	0.28	0.84	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	515.32	35.09	6.30	0.85	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	100.01	2.81	0.33	0.83	0.33
paracentral gyrus, adult, pool1	10035-101E8	1139.91	22.61	1.65	3.94	3.66
parietal cortex, adult, donor10258	10373-105G4	754.56	6.61	4.40	2.20	2.94
parietal lobe - adult, donor10196	10171-103B9	699.72	11.29	0.94	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	769.03	5.99	3.14	0.86	1.43
parietal lobe, adult, pool1	10034-101E7	1164.77	19.12	1.50	4.76	2.47
parietal lobe, fetal, donor1	10072-101I9	106.68	0.97	0.97	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	505.46	11.96	2.62	1.50	1.12
parotid gland, adult	10199-103F1	130.12	1.23	0.62	0.00	0.00
penis, adult	10200-103F2	177.78	3.22	5.91	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	226.66	46.48	1.30	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	134.04	4.52	0.73	0.58	0.73
pineal gland - adult, donor10196	10179-103C8	392.82	14.84	0.65	1.29	1.94
pineal gland, adult, donor10252	10160-103A7	477.32	4.15	1.78	0.59	1.18
pineal gland, adult, donor10258	10377-105G8	390.67	7.52	5.64	0.63	3.14
pituitary gland - adult, donor10196	10180-103C9	298.48	36.42	3.04	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	607.70	21.37	2.08	2.61	2.61
pituitary gland, adult, donor10258	10378-105G9	291.12	0.85	1.70	0.00	1.70
placenta, adult, pool1	10021-101D3	89.87	2.47	0.22	0.86	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	27.41	2.12	0.00	0.93	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	560.77	49.96	1.71	0.93	0.62
pons, adult, pool1	10033-101E6	942.70	24.18	2.15	5.25	2.58
postcentral gyrus, adult, pool1	10032-101E5	965.82	18.74	2.62	3.84	3.05
promyelocytes/myelocytes PMC, donor1	12132-128D8	18.82	0.00	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	85.07	6.12	0.44	0.00	0.58
prostate cancer cell line:PC-3	10439-106E7	374.44	43.38	1.45	2.54	1.27
prostate, adult, pool1	10022-101D4	279.69	5.35	0.73	1.45	1.54
putamen, adult, donor10196	10176-103C5	964.08	25.02	4.01	5.19	4.72
putamen, adult, donor10252	10152-102I8	409.79	7.84	5.88	0.00	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	623.99	2.19	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	836.94	9.18	3.87	1.69	2.66
putamen, newborn, donor10223	10365-105F5	285.62	14.24	1.50	2.25	0.75
rectal cancer cell line:TT1TKB	10469-106I1	160.60	4.65	0.00	0.87	0.87
rectum, fetal, donor1	10067-101I4	90.41	0.00	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	154.97	5.51	1.06	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	54.26	2.49	0.41	4.14	0.00
retina, adult, pool1	10030-101E3	531.19	7.85	2.29	4.37	2.48
retinoblastoma cell line:Y79	10475-106I7	71.97	0.52	0.52	0.52	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	84.10	2.34	0.37	0.86	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	17.43	0.56	0.00	0.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	131.11	12.88	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	359.97	26.38	3.08	0.97	0.81
salivary acinar cells, donor2	11772-123I8	260.78	20.24	2.34	0.55	0.41
salivary acinar cells, donor3	11773-123I9	231.06	7.94	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	102.95	4.58	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	142.06	18.30	0.42	1.43	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	124.49	17.99	0.24	0.94	1.18
seminal vesicle, adult	10201-103F3	110.58	2.12	2.65	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	122.43	3.40	1.46	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	86.56	7.55	0.50	0.25	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	100.35	4.01	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	150.04	3.49	0.81	0.81	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	150.98	8.73	0.44	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	79.61	2.97	0.26	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	36.18	2.84	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	250.31	18.71	0.60	0.60	0.24
skeletal muscle, fetal, donor1	10066-101I3	35.18	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	189.99	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	131.30	2.52	0.00	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	61.70	0.00	0.00	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	113.47	2.21	0.63	0.95	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	8.87	0.19	0.00	0.19	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	68.73	1.48	0.49	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	138.17	0.32	0.97	0.48	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	166.49	3.27	0.00	1.31	1.53
small intestine, adult, pool1	10024-101D6	118.01	4.06	0.12	0.12	0.24
small intestine, fetal, donor1	10064-101I1	39.07	0.49	0.25	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	74.37	1.03	3.59	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	234.16	9.05	2.33	0.78	0.78
somatostatinoma cell line:QGP-1	10781-110G7	162.96	2.95	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	431.74	4.36	4.59	2.98	2.06
spinal cord, adult, donor10252	10159-103A6	574.85	3.15	0.39	3.15	1.18
spinal cord, adult, donor10258	10369-105F9	508.47	0.00	0.69	2.77	2.77
spinal cord, fetal, donor1	10056-101H2	237.23	0.61	1.83	2.44	1.83
spinal cord, newborn, donor10223	10359-105E8	297.57	7.81	0.46	1.38	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	148.61	8.51	0.45	0.75	0.15
spleen, adult, pool1	10025-101D7	130.07	1.76	0.22	1.43	0.22
spleen, fetal, pool1	10044-101F8	115.77	3.42	0.40	1.11	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	18.84	0.52	0.00	0.00	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	246.84	18.99	0.19	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	73.38	2.45	1.05	1.05	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	921.43	356.14	7.82	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	181.44	8.89	0.68	0.34	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	64.39	6.78	0.42	0.00	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	106.61	5.50	0.42	0.42	0.85
stomach, fetal, donor1	10062-101H8	98.25	4.27	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	90.58	2.85	1.14	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	651.29	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	702.05	4.78	3.32	2.49	1.25
substantia nigra, adult, donor10258	10371-105G2	746.39	5.17	3.10	4.14	2.59
substantia nigra, newborn, donor10223	10358-105E7	204.20	10.60	0.71	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	43.56	0.00	0.00	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	986.81	16.78	2.46	4.83	2.12
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	106.84	0.71	1.42	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	138.45	1.76	0.88	1.32	0.44
tenocyte, donor1	11763-123H8	110.32	13.27	0.70	1.40	0.00
tenocyte, donor2	11765-123I1	109.11	7.25	1.91	0.76	0.76
tenocyte, donor3	11768-123I4	94.89	7.78	1.48	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	41.30	1.53	0.34	1.02	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	6.17	0.00	0.15	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	48.66	4.96	0.15	0.62	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	205.65	33.77	1.52	2.79	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	110.80	32.52	0.38	3.78	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	169.26	21.81	0.11	2.40	1.96
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	26.06	13.03	0.98	0.33	0.00
testis, adult, pool1	10026-101D8	205.51	1.61	0.75	3.44	2.68
testis, adult, pool2	10096-102C6	179.08	1.35	0.45	3.61	2.26
thalamus - adult, donor10196	10168-103B6	822.47	4.42	6.62	2.21	2.21
thalamus, adult, donor10252	10154-103A1	843.46	4.84	1.72	1.72	2.50
thalamus, adult, donor10258, tech_rep1	10370-105G1	1356.40	1.54	1.54	3.08	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	456.52	6.59	5.76	1.98	1.15
thalamus, newborn, donor10223	10366-105F6	235.31	10.36	1.15	0.00	1.73
throat, adult	10209-103G2	90.38	2.25	0.75	0.75	0.75
throat, fetal, donor1	10061-101H7	66.12	1.52	0.30	0.00	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	34.98	0.60	0.20	0.00	0.20
thymus, adult, pool1	10027-101D9	46.23	0.30	0.00	0.99	0.40
thymus, fetal, pool1	10043-101F7	77.62	3.12	0.21	0.94	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	283.07	33.11	2.26	0.80	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	187.60	17.88	1.12	0.14	0.28
thyroid, adult, pool1	10028-101E1	190.08	4.39	0.47	1.59	1.03
thyroid, fetal, donor1	10060-101H6	63.28	1.58	0.79	1.05	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	128.62	6.28	0.93	0.70	0.23
tongue, fetal, donor1	10059-101H5	121.38	1.97	1.58	1.97	1.58
tonsil, adult, pool1	10047-101G2	147.86	5.91	0.40	0.00	0.30
trachea, adult, pool1	10029-101E2	149.94	5.48	0.57	0.33	0.65
trachea, fetal, donor1	10058-101H4	83.86	4.23	0.77	1.92	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	163.32	7.09	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	225.02	35.16	0.41	0.20	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	65.18	5.33	0.16	0.94	0.16
tridermal teratoma cell line:HGRT	10694-109G1	43.76	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	135.10	3.81	0.34	0.85	0.68
umbilical cord, fetal, donor1	10057-101H3	39.64	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	261.91	14.50	0.34	2.56	2.22
uterus, fetal, donor1	10055-101H1	103.92	3.07	0.00	1.02	1.54
vagina, adult	10204-103F6	227.46	4.52	0.65	1.29	0.00
vein, adult	10191-103E2	122.75	2.41	0.22	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.48	1.07	0.00	0.00	0.00